Elasmogen
is a Scotland-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer and inflammatory diseases... Read moreElasmogen
is a Scotland-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer and inflammatory diseases... Read more
News
May 18, 2022
DailyBusiness
Elasmogen: Biopharma firm Elasmogen raises 8m for drugs pipeline
May 18, 2022
Insider co uk
Elasmogen: BGF, SNIB and Scottish Enterprise invest 8 million in Elasmogen
Jan 27, 2021
Pharmabiz
Elasmogen: Elasmogen in collaboration with US research partners identify nextgeneration proteinbased antiCovid19 therapeutic candidates
Dec 09, 2020
FinanzNachrichten
Elasmogen: Elasmogen Announces Grants Of 2 New VNAR and soloMER Patent Families
Jan 13, 2020
BioPortfolio
Elasmogen: Elasmogen secures £2m to support next gen biologics
Jan 13, 2020
EU-Startups
Elasmogen: Scottish Elasmogen raises €2.3 million to beat cancer based on protein found in sharks
Jan 10, 2020
DailyBusiness
Elasmogen: £2m for Elasmogen's shark-inspired drugs treatments
Jan 16, 2019
The Pharma Letter
Elasmogen: BRIEF-Elasmogen and ImmunoForge agree licensing deal
Oct 18, 2018
BioPortfolio
Elasmogen: Elasmogen Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Aug 13, 2018
Outsourcing-Pharma
Elasmogen: Almac and Elasmogen receive £2m grant for oncology research
Elasmogen Competitors
1
2
3
4
5
6
7
8
9
10